EVLA (Group 1, n = 149)

RFA (Group 2, n = 134)

P Value

Operation Time (min)

19.19 ± 5.44

19.71 ± 6.62

NS

GSV Length(cm)

38.92 ± 6.88

41.83 ± 4.82

P < 0.001

Tumescent (ml)

343.18 ± 61.93

332.72 ± 70.11

NS

Hematoma n (%)

2 (1.3%)

1 (0.7%)

NS

Ecchymosis n (%)

13 (8.7%)

8 (6%)

NS

Edema n (%)

21 (14.1%)

12 (9%)

NS

Paresthesia n (%)

10 (6.7%)

6 (4.5%)

NS

Burn n (%)

0 (0%)

0 (0%)

NS

DVT n (%)

0 (0%)

0 (0%)

NS

PE n (%)

0 (0%)

0 (0%)

NS

Phlebitis n (%)

3 (2%)

2 (1.5%)

NS

Pain n (%)

31 (20.8%)

19 (14.2%)

NS

VCSS

Preoperative

9.37 ± 0.99

8.91 ± 1.00

P < 0.001

Postoperative 10^th day

4.56 ± 1.24

3.84 ± 1.11

P < 0.001

Postoperative 1^st month

3.73 ± 1.37

3.69 ± 1.24

NS

Postoperative 3^rd month

2.84 ± 1.08

3.03 ± 1.13

NS

Postoperative 6^th month

1.83 ± 0.74

1.81 ± 0.74

NS

RDA

2.10 ± 0.89

1.89 ± 0.89

NS

GSV Occlusion

145 (96.6%)

136 (98.5%)

NS